Ranbaxy gets FDA approval for Novartis's Diovan generic

Ranbaxy Laboratories Ltd has received approval from the U.S. Food and Drug Administration (FDA) to launch a cheaper copy of Novartis AG's blood pressure pill Diovan, bolstering its outlook after a raft of regulatory bans for poor production quality at its

http://in.reuters.com/article/2014/06/27/us-ranbaxy-lab-fda-idINKBN0F12HF20140627

YOU ARE BEING REDIRECTED TO THE ARTICLE
. . .
× CLOSE

PROCESSING